Characterising treatment outcomes of patients achieving quarterly aflibercept dosing for neovascular age-related macular degeneration: real-world clinical outcomes from a large tertiary care centre
- Publication date
- 9 September 2022
- Publisher
- 'Springer Science and Business Media LLC'